Diabetes [clinicaltrials_resource:52d261e9ebc332373e9c8a0abb6bd605]
Prevalence of Carbohydrate Intolerance in Lean and Obese Children [clinicaltrials:NCT00000112]Diabetes and Heart Disease Risk in Blacks [clinicaltrials:NCT00001853]Family-Centered Diabetes Project [clinicaltrials:NCT00006159]Improving Service Delivery Through Access Points [clinicaltrials:NCT00012623]Improving Diabetes Care Via Telephone Assessment and Patient Education [clinicaltrials:NCT00012649]Developing and Implementing a Quality Measure for Glycemic Control [clinicaltrials:NCT00012675]Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care [clinicaltrials:NCT00012753]Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program [clinicaltrials:NCT00013052]Look AHEAD: Action for Health in Diabetes [clinicaltrials:NCT00017953]Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans [clinicaltrials:NCT00018486]Improving Compliance With Metformin [clinicaltrials:NCT00018616]Clinical Trial of Footwear in Patients With Diabetes [clinicaltrials:NCT00032864]Research Study in Patients With Persistent Macular Edema [clinicaltrials:NCT00035906]Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus [clinicaltrials:NCT00057304]Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus [clinicaltrials:NCT00057317]Differential Metabolism of Dietary Fatty Acids [clinicaltrials:NCT00059254]Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes [clinicaltrials:NCT00065130]Gene Therapy to Improve Wound Healing in Patients With Diabetes [clinicaltrials:NCT00065663]ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence [clinicaltrials:NCT00069368]Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population [clinicaltrials:NCT00071448]Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL [clinicaltrials:NCT00079638]Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression [clinicaltrials:NCT00090506]clinicaltrials:NCT00091949Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes [clinicaltrials:NCT00095082]NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes [clinicaltrials:NCT00095446]Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents [clinicaltrials:NCT00097071]Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes [clinicaltrials:NCT00097084]Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes [clinicaltrials:NCT00097279]Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes [clinicaltrials:NCT00097877]INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study [clinicaltrials:NCT00101751]Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes [clinicaltrials:NCT00104182]clinicaltrials:NCT00104572An Evaluation of Home-Based Telemedicine Services [clinicaltrials:NCT00105846]Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes [clinicaltrials:NCT00106366]Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance [clinicaltrials:NCT00108615]A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump [clinicaltrials:NCT00115973]A Lifestyle and Combination Medication Therapy Diabetes Prevention Study [clinicaltrials:NCT00116922]Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes [clinicaltrials:NCT00117780]clinicaltrials:NCT00117793Novofine Autocover Safety Needle Versus BD Safety Glide [clinicaltrials:NCT00121355]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT00930397 [clinicaltrials_resource:07c252cac911421c26e69c52e4b16b2f]eligibility for clinicaltrials:NCT00548639 [clinicaltrials_resource:0921b98acf2358e280ce1e1c774b11c7]eligibility for clinicaltrials:NCT00174785 [clinicaltrials_resource:0db5002442ffc4092822dd0f1dba6979]eligibility for clinicaltrials:NCT00242632 [clinicaltrials_resource:13b4fbaf7858a20d31cd047633bd5c8e]eligibility for clinicaltrials:NCT01809730 [clinicaltrials_resource:260899a71d0801c1b2f7672304cbd0a3]eligibility for clinicaltrials:NCT01377727 [clinicaltrials_resource:3d182b9e7267f52b32d1d808059f114b]eligibility for clinicaltrials:NCT01564485 [clinicaltrials_resource:5721e0cbf3fd2bcc7aded82be1450854]eligibility for clinicaltrials:NCT01213784 [clinicaltrials_resource:58154bb7ee33ff1f9d9295db060e73ce]eligibility for clinicaltrials:NCT00160927 [clinicaltrials_resource:5b6a8210e75c69d4166578bffbc536d7]eligibility for clinicaltrials:NCT01837069 [clinicaltrials_resource:8543ab1a050d7f2766cb676745af1145]eligibility for clinicaltrials:NCT02325726 [clinicaltrials_resource:8fba18c7a554a9293351e0ba3a00aedb]eligibility for clinicaltrials:NCT02384447 [clinicaltrials_resource:9a0dde736d3a558f9fb4afb162f14c69]eligibility for clinicaltrials:NCT00465634 [clinicaltrials_resource:9e9e9d79fa4e9689ace0ad38cd19d466]eligibility for clinicaltrials:NCT02407626 [clinicaltrials_resource:a736fc6d6f33aeed5159b045797df376]eligibility for clinicaltrials:NCT00786279 [clinicaltrials_resource:bbfe7f38a8e551fc74ebf2132329ba7e]eligibility for clinicaltrials:NCT02341664 [clinicaltrials_resource:befb69b3c8fc8466c4adf5138f4dcb58]eligibility for clinicaltrials:NCT01618409 [clinicaltrials_resource:c4a211cca031713a3ad43213b4c9a211]eligibility for clinicaltrials:NCT01384136 [clinicaltrials_resource:c68bc25f35afc7ad4d3621afc2a38374]eligibility for clinicaltrials:NCT01027988 [clinicaltrials_resource:cb1ca86f8e5a4e99dbc1e3b164adf992]eligibility for clinicaltrials:NCT01073137 [clinicaltrials_resource:d03028c7d788af52644327e922073ad5]eligibility for clinicaltrials:NCT00817973 [clinicaltrials_resource:d2fe5fca9ddcae24ed11b38a5a101368]eligibility for clinicaltrials:NCT01084993 [clinicaltrials_resource:e7aa4e58020f6ad7a0fa16e739a1450d]eligibility for clinicaltrials:NCT01996995 [clinicaltrials_resource:ef31ed519806876ed989be58d23ba8ec]eligibility for clinicaltrials:NCT00234871 [clinicaltrials_resource:f1a7f3e42691d70954876efd74cb19cd]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00930397 [clinicaltrials_resource:07c252cac911421c26e69c52e4b16b2f]eligibility for clinicaltrials:NCT00548639 [clinicaltrials_resource:0921b98acf2358e280ce1e1c774b11c7]eligibility for clinicaltrials:NCT00174785 [clinicaltrials_resource:0db5002442ffc4092822dd0f1dba6979]eligibility for clinicaltrials:NCT01136096 [clinicaltrials_resource:0e5bd17cb406b2c0d46ae176fb5f4dc0]eligibility for clinicaltrials:NCT00242632 [clinicaltrials_resource:13b4fbaf7858a20d31cd047633bd5c8e]eligibility for clinicaltrials:NCT01521312 [clinicaltrials_resource:22b88aa22ebf04654397051099a2ec2d]eligibility for clinicaltrials:NCT01809730 [clinicaltrials_resource:260899a71d0801c1b2f7672304cbd0a3]eligibility for clinicaltrials:NCT00902824 [clinicaltrials_resource:3c29aadb5cb115502acf4637b076600d]eligibility for clinicaltrials:NCT01377727 [clinicaltrials_resource:3d182b9e7267f52b32d1d808059f114b]eligibility for clinicaltrials:NCT01982981 [clinicaltrials_resource:46da1d90a5decc52e3c19e965ce0dd9d]eligibility for clinicaltrials:NCT00309283 [clinicaltrials_resource:5692e139daec8412ca6e01dd5cd67792]eligibility for clinicaltrials:NCT01564485 [clinicaltrials_resource:5721e0cbf3fd2bcc7aded82be1450854]eligibility for clinicaltrials:NCT01213784 [clinicaltrials_resource:58154bb7ee33ff1f9d9295db060e73ce]eligibility for clinicaltrials:NCT00160927 [clinicaltrials_resource:5b6a8210e75c69d4166578bffbc536d7]eligibility for clinicaltrials:NCT00806962 [clinicaltrials_resource:679f695570b2d96799db33c8f0c6d7c9]eligibility for clinicaltrials:NCT01097564 [clinicaltrials_resource:688dc2a8d2c5158430082c6a540b793c]eligibility for clinicaltrials:NCT00326872 [clinicaltrials_resource:73ca1283e77af9844082e47a1599e117]eligibility for clinicaltrials:NCT01837069 [clinicaltrials_resource:8543ab1a050d7f2766cb676745af1145]eligibility for clinicaltrials:NCT02325726 [clinicaltrials_resource:8fba18c7a554a9293351e0ba3a00aedb]eligibility for clinicaltrials:NCT02384447 [clinicaltrials_resource:9a0dde736d3a558f9fb4afb162f14c69]eligibility for clinicaltrials:NCT00465634 [clinicaltrials_resource:9e9e9d79fa4e9689ace0ad38cd19d466]eligibility for clinicaltrials:NCT02407626 [clinicaltrials_resource:a736fc6d6f33aeed5159b045797df376]eligibility for clinicaltrials:NCT00786279 [clinicaltrials_resource:bbfe7f38a8e551fc74ebf2132329ba7e]eligibility for clinicaltrials:NCT02341664 [clinicaltrials_resource:befb69b3c8fc8466c4adf5138f4dcb58]eligibility for clinicaltrials:NCT01618409 [clinicaltrials_resource:c4a211cca031713a3ad43213b4c9a211]eligibility for clinicaltrials:NCT01384136 [clinicaltrials_resource:c68bc25f35afc7ad4d3621afc2a38374]eligibility for clinicaltrials:NCT00379652 [clinicaltrials_resource:c80f6c0e3764a3dbd645d9725501f41e]eligibility for clinicaltrials:NCT01027988 [clinicaltrials_resource:cb1ca86f8e5a4e99dbc1e3b164adf992]eligibility for clinicaltrials:NCT01073137 [clinicaltrials_resource:d03028c7d788af52644327e922073ad5]eligibility for clinicaltrials:NCT00817973 [clinicaltrials_resource:d2fe5fca9ddcae24ed11b38a5a101368]eligibility for clinicaltrials:NCT01084993 [clinicaltrials_resource:e7aa4e58020f6ad7a0fa16e739a1450d]eligibility for clinicaltrials:NCT01996995 [clinicaltrials_resource:ef31ed519806876ed989be58d23ba8ec]eligibility for clinicaltrials:NCT00234871 [clinicaltrials_resource:f1a7f3e42691d70954876efd74cb19cd]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Diabetes [clinicaltrials_resource:52d261e9ebc332373e9c8a0abb6bd605]
Bio2RDF identifier
52d261e9ebc332373e9c8a0abb6bd605
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:52d261e9ebc332373e9c8a0abb6bd605
identifier
clinicaltrials_resource:52d261e9ebc332373e9c8a0abb6bd605
title
Diabetes
@en
label
Diabetes [clinicaltrials_resource:52d261e9ebc332373e9c8a0abb6bd605]
@en